{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T17:17:21Z","timestamp":1726507041972},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"35","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>\n                                 <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic> prosthetic valve endocarditis (SAPVE) has a poor prognosis. There are no large series that accurately describe this entity.<\/jats:p>\n            <jats:p>This is a retrospective observational study on a prospective cohort from 3 Spanish reference hospitals for cardiac surgery, including 78 definitive episodes of left SAPVE between 1996 and 2016.<\/jats:p>\n            <jats:p>Fifty percent had a Charlson Index score &gt;5; 53% were health care-related. Twenty percent did not present fever. Complications at diagnosis included: severe heart failure (HF, 29%), septic shock (SS, 17.9%), central nervous system abnormalities (19%), septic metastasis (4%). Hemorrhagic stroke was not higher in anticoagulated patients. Twenty-seven percent were methicilin-resistant SA (MRSA). Fifteen of 31 had positive valve culture; it was related to surgery within first 24\u200ahours. At diagnosis, 69% had vegetation (&gt;10\u200amm in 75%), 21.8% perianular extension, and 20% prosthetic dehiscence. Forty-eight percent had persistent bacteremia, related to nonsurgical treatment. Perianular extension progressed in 18%. Surgery was performed in 35 episodes (12 with stroke). Eleven uncomplicated episodes were managed with medical therapy, 8 survived. In-hospital mortality was 55%, higher in episodes with hemorrhagic stroke (77.8% vs 52.2%, odds ratio 3.2 [0.62\u201316.55]). Early SAPVE was nosocomial (92%), presented as severe HF (54%), patients were diagnosed and operated on early, 38% died. In intermediate SAPVE (9 weeks\u20131 year) diagnosis was delayed (24%), patients presented with constitutional syndrome (18%), renal failure (41%), and underwent surgery &gt;72\u200ahours after indication; 53% died. Late SAPVE (&gt;1 year) was related with health care, diagnosis delay, and 60% of deceases.<\/jats:p>\n            <jats:p>Left <jats:italic toggle=\"yes\">SA<\/jats:italic>PVE frequently affected patients with comorbidity and health care contact. Complications at diagnosis and absence of fever were frequent. Presence of MRSA was high. Positive valve culture was related to early surgery. Paravalvular extension was frequent; vegetations were large, but its absence at diagnosis was common. Some uncomplicated SAPVE episodes were safety treated with medical therapy. Surgery was feasible in patients with stroke. Mortality was high. There were differences in some clinical characteristics and in evolution according to the time elapsed from valve replacement. Prognosis was better in early SAPVE.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000016903","type":"journal-article","created":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T14:30:50Z","timestamp":1567089050000},"page":"e16903","source":"Crossref","is-referenced-by-count":3,"title":["\u201cA contemporary description of staphylococcus aureus prosthetic valve endocarditis. Differences according to the time elapsed from surgery\u201d"],"prefix":"10.1097","volume":"98","author":[{"given":"Carmen","family":"S\u00e1ez","sequence":"first","affiliation":[{"name":"Department of Medicine-Infectious diseases, Instituto de Investigaci\u00f3n Sanitaria, Hospital Universitario de la Princesa, Universidad Aut\u00f3noma de Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Sarri\u00e1","sequence":"additional","affiliation":[{"name":"Department of Medicine-Infectious diseases, Instituto de Investigaci\u00f3n Sanitaria, Hospital Universitario de la Princesa, Universidad Aut\u00f3noma de Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isidre","family":"Vilacosta","sequence":"additional","affiliation":[{"name":"Instituto Cardiovascular. Hospital Universitario Cl\u00ednico San Carlos, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Olmos","sequence":"additional","affiliation":[{"name":"Instituto Cardiovascular. Hospital Universitario Cl\u00ednico San Carlos, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"L\u00f3pez","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Instituto de Ciencias del Coraz\u00f3n (ICICOR), CIBERCV, Hospital Cl\u00ednico Universitario de Valladolid, Valladolid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo Elpidio","family":"Garc\u00eda-Granja","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Instituto de Ciencias del Coraz\u00f3n (ICICOR), CIBERCV, Hospital Cl\u00ednico Universitario de Valladolid, Valladolid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Instituto Cardiovascular. Hospital Universitario Cl\u00ednico San Carlos, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"de las Cuevas","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Hospital Universitario de la Princesa, Instituto de Investigaci\u00f3n Sanitaria, Universidad Aut\u00f3noma de Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Reyes","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Hospital Universitario de la Princesa, Instituto de Investigaci\u00f3n Sanitaria, Universidad Aut\u00f3noma de Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes","family":"Dom\u00ednguez","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital Universitario de la Princesa, Instituto de Investigaci\u00f3n Sanitaria, Universidad Aut\u00f3noma de Madrid, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Alberto","family":"San Rom\u00e1n","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Instituto de Ciencias del Coraz\u00f3n (ICICOR), CIBERCV, Hospital Cl\u00ednico Universitario de Valladolid, Valladolid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1001\/jama.297.12.1354","article-title":"International Collaboration on Endocarditis Prospective Cohort Study Investigators. Contemporary clinical profile and outcome of prosthetic valve endocarditis","volume":"297","author":"Wang","year":"2007","journal-title":"JAMA"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1086\/516378","article-title":"Staphylococcus aureus prosthetic valve endocarditis: optimal management and risk factors for death","volume":"26","author":"John","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.amjmed.2005.09.037","article-title":"Medical versus surgical management of Staphylococcus aureus prosthetic valve endocarditis","volume":"119","author":"Sohail","year":"2006","journal-title":"Am J Med"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1086\/383035","article-title":"Prognostic factors in 61 cases of Staphylococcus aureus prosthetic valve infective endocarditis from the International Collaboration on Endocarditis merged database. International Collaboration on Endocarditis Study Group","volume":"38","author":"Chirouze","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/clinids\/22.2.276","article-title":"Infective endocarditis: review of 135 cases over 9 years","volume":"22","author":"Sandre","year":"1996","journal-title":"Clin Infect Dis"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.ejcts.2004.08.007","article-title":"Surgical results for active endocarditis with prosthetic valve replacement: impact of culture-negative endocarditis on early and late outcomes","volume":"26","author":"Murashita","year":"2004","journal-title":"Eur J Cardiothorac Surg"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1378\/chest.128.2.764","article-title":"The impact of hospital-acquired infections on the microbial etiology and prognosis of late-onset prosthetic valve endocarditis","volume":"128","author":"Rivas","year":"2005","journal-title":"Chest"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/eurheartj\/ehl486","article-title":"Definition, clinical profile, microbiological spectrum, and prognostic factors of early-onset prosthetic valve endocarditis","volume":"28","author":"L\u00f3pez","year":"2007","journal-title":"Eur Heart J"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.amjmed.2004.12.017","article-title":"Risk of endocarditis among patients with prosthetic valves and Staphylococcus aureus bacteremia","volume":"118","author":"El-Ahdab","year":"2005","journal-title":"Am J Med"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.3201\/eid\/1706.101037","article-title":"High vancomycin MIC and complicated methicillin-susceptible staphylococcus aureus bacteremia","volume":"17","author":"Aguado","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/infdis\/jir270","article-title":"Antibiotic choice may not explain poorer outcomes in patients with staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations","volume":"204","author":"Holmes","year":"2011","journal-title":"J Infect Dis"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1093\/cid\/ciu183","article-title":"Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis","volume":"58","author":"Cervera","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1128\/JCM.41.1.5-14.2003","article-title":"Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus","volume":"41","author":"Cui","year":"2003","journal-title":"J Clin Microbiol"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1086\/596511","article-title":"Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection","volume":"199","author":"Peleg","year":"2009","journal-title":"J Infect Dis"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1128\/AAC.00113-08","article-title":"Relationship between Vancomycin MIC and failure among patients with MRSA bacteremia treated with vancomycin","volume":"52","author":"Lodise","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","article-title":"High-dose vancomycin therapy for methicillin-resistant staphylococcus aureus infections: efficacy and toxicity","volume":"166","author":"Hidayat","year":"2006","journal-title":"Arch Intern Med"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/524667","article-title":"Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"46","author":"Soriano","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/cid\/cir124","article-title":"Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets","volume":"52","author":"Kullar","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/cid\/cir935","article-title":"The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis","volume":"54","author":"Van Hal","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijantimicag.2012.04.003","article-title":"High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia","volume":"40","author":"Wi","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"R22-20230914","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1128\/AAC.00939-06","article-title":"Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia","volume":"51","author":"Moise","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"R23-20230914","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/jac\/dkq050","article-title":"Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin","volume":"65","author":"Yoon","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"R24-20230914","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0b013e318194da65","article-title":"Endocarditis caused by Staphylococcus aureus: a reappraisal of the epidemiologic, clinical, and pathologic manifestations with analysis of factors determining outcome","volume":"88","author":"Fern\u00e1ndez Guerrero","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"R25-20230914","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.ahj.2007.06.028","article-title":"Abscess in infective endocarditis: the value of transesophageal echocardiography and outcome: a 5-year study","volume":"154","author":"Hill","year":"2007","journal-title":"Am Heart J"},{"key":"R26-20230914","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/0003-4975(94)90458-8","article-title":"Prosthetic valve endocarditis: superiority of surgical valve replacement versus medical therapy only","volume":"58","author":"Yu","year":"1994","journal-title":"Ann Thorac Surg"},{"key":"R27-20230914","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1378\/chest.108.3.688","article-title":"Prosthetic valve endocarditis in the ICU: prognostic factors of overall survival in a series of 122 cases and consequences for treatment decisions","volume":"108","author":"Wolff","year":"1995","journal-title":"Chest"},{"key":"R28-20230914","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/icvts\/ivs372","article-title":"Do all patients with prosthetic valve endocarditis need surgery?","volume":"15","author":"Attaran","year":"2012","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"R29-20230914","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/archinte.159.5.473","article-title":"Infective endocarditis due to Staphylococcus aureus: deleterious effect of anticoagulant therapy","volume":"159","author":"Tornos","year":"1999","journal-title":"Arch Intern Med"},{"key":"R30-20230914","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/00365540902896061","article-title":"Major cerebral events in Staphylococcus aureus infective endocarditis: is anticoagulant therapy safe?","volume":"41","author":"Rasmussen","year":"2009","journal-title":"Scand J Infect Dis"},{"key":"R31-20230914","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/cid\/ciu877","article-title":"Editorial commentary: surgical therapy for Staphylococcus aureus prosthetic valve endocarditis: proceed with caution (Caveat Emptor)","volume":"60","author":"Karchmer","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R32-20230914","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/313753","article-title":"Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis","volume":"30","author":"Li","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R33-20230914","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehp285","article-title":"ESC Committee for Practice Guidelines. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer","volume":"30","author":"Habib","year":"2009","journal-title":"Eur Heart J"},{"key":"R34-20230914","first-page":"131","article-title":"Relevance of clinical presentation and period of diagnosis in prosthetic valve endocarditis","volume":"19","author":"San Mart\u00edn","year":"2010","journal-title":"J Heart Valve Dis"},{"key":"R35-20230914","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","article-title":"2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM)","volume":"36","author":"Habib","year":"2015","journal-title":"Eur Heart J"},{"key":"R36-20230914","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1093\/eurheartj\/ehs336","article-title":"Contemporary epidemiology and prognosis of septic shock in infective endocarditis","volume":"34","author":"Olmos","year":"2013","journal-title":"Eur Heart J"},{"key":"R37-20230914","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/archinternmed.2008.603","article-title":"Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study","volume":"169","author":"Murdoch","year":"2009","journal-title":"Arch Intern Med"},{"key":"R38-20230914","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1093\/eurheartj\/ehq110","article-title":"Health care exposure and age in infective endocarditis: results of a contemporary population-based profile of 1536 patients in Australia","volume":"31","author":"Sy","year":"2010","journal-title":"Eur Heart J"},{"key":"R39-20230914","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJMra010082","article-title":"Infective endocarditis in adults","volume":"345","author":"Mylonakis","year":"2001","journal-title":"N Engl J Med"},{"key":"R40-20230914","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/00005792-200109000-00003","article-title":"Infective endocarditis\u2014a prospective study at the end of the twentieth century: new predisposing conditions, new etiologic agents, and still a high mortality","volume":"80","author":"Bouza","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"R41-20230914","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/heart.88.1.53","article-title":"Mortality from infective endocarditis: clinical predictors of outcome","volume":"88","author":"Wallace","year":"2002","journal-title":"Heart"},{"key":"R42-20230914","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/hrt.2003.032128","article-title":"Infective endocarditis in Europe: lessons from the Euro heart survey","volume":"91","author":"Tornos","year":"2005","journal-title":"Heart"},{"key":"R43-20230914","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/01.CIR.72.1.31","article-title":"Risk factors for the development of prosthetic valve endocarditis","volume":"72","author":"Calderwood","year":"1985","journal-title":"Circulation"},{"key":"R44-20230914","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/cid\/ciu871","article-title":"ICE Prospective Investigators. Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the International Collaboration of Endocarditis-Prospective Cohort Study","volume":"60","author":"Chirouze","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R45-20230914","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0732-8893(97)81804-4","article-title":"An outbreak of candida parapsilosis prosthetic valve endocarditis","volume":"29","author":"Diekema","year":"1997","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R46-20230914","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1001\/jama.293.24.3012","article-title":"Staphylococcus aureus endocarditis: a consequence of medical progress","volume":"293","author":"Fowler","year":"2005","journal-title":"JAMA"},{"key":"R47-20230914","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management","volume":"28","author":"Tong","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"R48-20230914","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/archinte.159.5.462","article-title":"Clinical features os Staphylococcus aureus endocarditis","volume":"159","author":"Roder","year":"1999","journal-title":"Arch Intern Med"},{"key":"R49-20230914","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00005792-198305000-00004","article-title":"Sande MA, with the national Collaborative Endocarditis Study Group. Staphylococcus aureus endocarditis: clinical manifestations in addicts and non addicts","volume":"62","author":"Chambers","year":"1983","journal-title":"Medicine (Baltimore)"},{"key":"R50-20230914","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.carpath.2006.05.002","article-title":"Pathology of infectious and inflammatory diseases in prosthetic heart valves","volume":"15","author":"Jegatheeswaran","year":"2006","journal-title":"Cardiovasc Pathol"},{"key":"R51-20230914","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1128\/AAC.01146-08","article-title":"Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: study of antibiotic combinations","volume":"53","author":"Nguyen","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R52-20230914","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1128\/AAC.01145-08","article-title":"Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype and revertant strains","volume":"53","author":"Nguyen","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R53-20230914","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/jac\/dkp346","article-title":"Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies","volume":"64","author":"Steenbergen","year":"2009","journal-title":"J Antimicrobial Chemother"},{"key":"R54-20230914","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jiac.2018.03.003","article-title":"Spanish Collaboration on Endocarditis \u2013 Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en Espa\u00f1a (GAMES). Gentamicin may have no effect on mortality of staphylococcal prosthetic valve endocarditis","volume":"24","author":"Ramos-Mart\u00ednez","year":"2018","journal-title":"J Infect Chemother"},{"key":"R55-20230914","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0735-1097(02)01790-4","article-title":"Risk of embolization after institution of antibiotic therapy for infective endocarditis","volume":"39","author":"Vilacosta","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R56-20230914","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/cid\/cis878","article-title":"Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke","volume":"56","author":"Barsic","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R57-20230914","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","article-title":"Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications. A Scientific Statement for Healthcare Professionals From the American Heart Association Endorsed by the Infectious Diseases Society of America","volume":"132","author":"Baddour","year":"2015","journal-title":"Circulation"},{"key":"R58-20230914","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jtcvs.2010.09.016","article-title":"Outcomes for endocarditis surgery in North America: a simplified risk scoring system","volume":"141","author":"Gaca","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R59-20230914","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/eurheartj\/16.suppl_B.32","article-title":"Early infective endocarditis on prosthetic valves","volume":"16","author":"Chastre","year":"1995","journal-title":"Eur Heart J"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201908300-00034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T21:46:18Z","timestamp":1694727978000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201908300-00034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":58,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000016903","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8]]}}}